Clinical trials
Phase 1/2 Carcinoma, Merkel Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
| Recruiting | 10 |
| Completed | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Incyte Biosciences International Sàrl | 3 |
| Ariceum Therapeutics GmbH | 1 |
| Arvinas Inc. | 1 |
| AstraZeneca | 1 |
| Aulos Bioscience, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Exicure, Inc. | 1 |
| ImmunityBio, Inc. | 1 |
| Kartos Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Merkel Cell | 32 |
| Melanoma | 18 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Carcinoma, Renal Cell | 11 |
| Squamous Cell Carcinoma of Head and Neck | 11 |
| Stomach Neoplasms | 11 |
| Uterine Cervical Neoplasms | 11 |
| Neoplasm Metastasis | 10 |
| Triple Negative Breast Neoplasms | 10 |
| Carcinoma, Hepatocellular | 7 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.